Default company panoramic image
Logo

NOVACYT

NOVACYT is at this time seeking 500K€ for a bridge before rising 7M€ in Q2 2012 for its international development , knowing that one of the biggest and famous A

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Vélizy-Villacoublay, IDF, France
  • Currency EUR
  • Employees 6
  • Website novacyt.com

Company Summary

NOVACYT founded in 2006, has developed and commercializes from 2 years now a breakthrough cancer screening solution in the field of liquid based cytology.

The global market of these tests will be of 200M tests in 2015 with a fast growing in the BRICS for which NOVACYT has developed a high quality and affordable test.

Thanks to already marketed and international validated products, NOVACYT is ready to have an offensive strategy in the BRICS.

Team

  • Default avatar
    Eric Louis PELTIER
    CEO

    CAREER-EDUCATION:
    Awardwinner of the Medical University of Saint Antoine
    1991-1995 : Internship at « Hôpitaux de Paris »
    1994 : Master in Molecular Biology (Paris VI)
    1996 : Medical Doctor degree, Jury’s congratulations
    1998 : Master in « Health System and Society » (Paris VII)
    2005 : University degree in Coloscopy (Paris)

    RESEARCH AND TEACHING CHAIRS:
    1996 – 1998 : Assistant Paris’s Hospitals & Universities
    1998 – 1999 : Physician

  • Default avatar
    Jean Pierre CRINELLI
    COO

    EDUCATION:
    1975 : ESC - Le Havre Business School
    1976 : DECS
    1993 : HEC/Cesa Strategic Management - Paris Business School

    PROFESSIONAL EXPERIENCE:
    1977 - 1984 : COMPAGNIE EUROPEENNE D’ACCUMULATEURS (CEAc)
    *1983 - 1984 : Director International Affaires
    *1982 : Managing Director Fulmen UK & Hollande
    *1979 - 1981 : Sales Manager OEM outside France

Advisors

  • Default avatar
    LAVOIX
    Lawyer
    Unconfirmed
    Default avatar
    REVISA
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    AURINVEST 2
    Unconfirmed